Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Optimizerx Corp (OPRX)

Optimizerx Corp (OPRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 654,220
  • Shares Outstanding, K 15,109
  • Annual Sales, $ 43,310 K
  • Annual Income, $ -2,210 K
  • 60-Month Beta 0.67
  • Price/Sales 16.00
  • Price/Cash Flow N/A
  • Price/Book 17.07
Trade OPRX with:

Options Overview

Details
  • Implied Volatility 94.50%
  • Historical Volatility 97.11%
  • IV Percentile 83%
  • IV Rank 17.94%
  • IV High 297.01% on 03/06/20
  • IV Low 50.23% on 11/23/20
  • Put/Call Vol Ratio 0.14
  • Today's Volume 947
  • Volume Avg (30-Day) 844
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 7,680
  • Open Int (30-Day) 7,111

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.03
  • Number of Estimates 3
  • High Estimate -0.02
  • Low Estimate -0.05
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +80.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
39.06 +10.86%
on 03/05/21
63.98 -32.32%
on 02/16/21
-8.66 (-16.67%)
since 02/05/21
3-Month
27.71 +56.26%
on 12/07/20
63.98 -32.32%
on 02/16/21
+14.89 (+52.41%)
since 12/04/20
52-Week
6.50 +565.96%
on 03/16/20
63.98 -32.32%
on 02/16/21
+36.22 (+511.58%)
since 03/05/20

Most Recent Stories

More News
OptimizeRx to Participate at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021

OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to present at the 33 Annual ROTH Growth Conference...

OPRX : 43.30 (-5.58%)
DLA Piper advises William Blair & Company and RBC Capital Markets as joint book-running managers in OptimizeRx Corporation's US$75.5 million underwritten public offering

, /PRNewswire/ -- DLA Piper represented & Company, LLC and RBC Capital Markets, LLC as joint book-running managers in connection with an underwritten public offering of 1,523,750 shares of common stock...

OPRX : 43.30 (-5.58%)
OptimizeRx Corp. (OPRX) Soars 12%: Is Further Upside Left in the Stock?

OptimizeRx Corp. (OPRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down...

OPRX : 43.30 (-5.58%)
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Surpass Estimates

OptimizeRx Corp. (OPRX) delivered earnings and revenue surprises of 6.67% and 2.53%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

OPRX : 43.30 (-5.58%)
OptimizeRx Reports Q4 2020 Revenue Up 123% to Record $16.4 Million, Driving Net Income of $1.4 Million or $0.08 Per Share

OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported results for the fourth quarter and full year ended December...

OPRX : 43.30 (-5.58%)
OptimizeRx Corp. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 24, 2021 / OptimizeRx Corp. (NASDAQ:OPRX) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 24, 2021 at 4:30...

OPRX : 43.30 (-5.58%)
OptimizeRx's Angelo Campano Named to MM+M 40 Under 40 List

OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced its senior vice president and principal of agency channels,...

OPRX : 43.30 (-5.58%)
OptimizeRx Corp. (OPRX) to Report Q4 Results: Wall Street Expects Earnings Growth

OptimizeRx Corp. (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OPRX : 43.30 (-5.58%)
OptimizeRx Sets Fourth Quarter and Full Year 2020 Conference Call for Wednesday, February 24, 2021 at 4:30 p.m. ET

OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a conference call on Wednesday, February 24, 2021 at...

OPRX : 43.30 (-5.58%)
OptimizeRx to Present at the SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021

OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to present at the SVB Leerink 10 Annual Global...

OPRX : 43.30 (-5.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

OptimizeRx Corporation provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products. It offers pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company offers...

See More

Key Turning Points

3rd Resistance Point 57.62
2nd Resistance Point 53.06
1st Resistance Point 48.18
Last Price 43.30
1st Support Level 38.74
2nd Support Level 34.18
3rd Support Level 29.30

See More

52-Week High 63.98
Last Price 43.30
Fibonacci 61.8% 42.02
Fibonacci 50% 35.24
Fibonacci 38.2% 28.46
52-Week Low 6.50

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar